GLP-1 Orders for Patients with Diabetes Q1 2026 Quarterly rates per 100,000 of patients with documentation of type 2 diabetes and receiving clinical care receiving a prescription, dispense, or reporting starting a GLP-1 medication
Circulating but not faecal short-chain fatty acids are related to insulin sensitivity, lipolysis and GLP-1 concentrations in humans
We strive to optimize the benefits of GLP-1 medications, including their potential cardiovascular advantages, to enhance the overall well-being of our patients
Technology Platform: User-Friendly: Easy to navigate website/app Secure patient portal Clear instructions Works on mobile and desktop HIPAA-compliant security Issues: Confusing interface Frequent technical problems Poor mobile experience Security concerns No patient portal Questions to Ask Before Choosing: Essential Questions: Which providers will I see, and are they licensed in my state? What pharmacy will fill my prescription, and are they FDA-registered? Whats included in the monthly price? How often are follow-up appointments, and are they included? Can I choose between semaglutide and tirzepatide? What happens if I experience side effects? How do refills work? Whats your cancellation policy? Do you accept HSA/FSA? How quickly can I get started? If provider cant answer these clearly, thats a red flag
However, the sticker shock of the full upfront payment, often $1,200 or more for a 6-month plan, is a common complaint for new users expecting a monthly bill
The New England Journal of Medicine, 389 (10), 877888
